Prospects for reconsolidation-focused treatments of substance use and anxiety-related disorders

被引:16
|
作者
Paulus, Daniel J. [1 ,2 ]
Kamboj, Sunjeev K. [3 ]
Das, Ravi K. [3 ]
Saladin, Michael E. [1 ,4 ]
机构
[1] Med Univ South Carolina, Dept Psychiat & Behav Sci, Charleston, SC 29425 USA
[2] Univ Houston, Dept Psychol, Houston, TX USA
[3] UCL, Res Dept Clin Educ & Hlth Psychol, Clin Psychopharamacol Unit, London, England
[4] Med Univ South Carolina, Coll Hlth Profess, Dept Hlth Sci & Res, Charleston, SC 29425 USA
关键词
MEMORY RECONSOLIDATION; FEAR; PROPRANOLOL; BEHAVIOR; INTERVENTION; BLOCKADE; EXPOSURE; ALCOHOL; PREVENT; RETURN;
D O I
10.1016/j.copsyc.2019.03.001
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
Memories are often conceptualized as permanent entities; however, retrieval of memories via stimulus prompts can return them to an active state, which initiates a period of lability before the memories are reconsolidated into long-term storage. Importantly, during this period, memories can be disrupted/ altered. A growing body of work has focused on translating animal and experimental science into reconsolidation-based interventions for clinical disorders maintained by maladaptive memories. Interventions targeting reward-based and fear-based memories undergirding substance use and anxiety-related disorders, respectively, have shown significant potential. There are several promising pharmacological agents and behavioral approaches that have been used to therapeutically target memory reconsolidation. Here, we discuss the current state of science with special emphasis on the clinical utility of these approaches.
引用
收藏
页码:80 / 86
页数:7
相关论文
共 50 条
  • [21] Mechanisms of comorbidity, continuity, and discontinuity in anxiety-related disorders
    McNaughton, Neil
    Corr, Philip J.
    DEVELOPMENT AND PSYCHOPATHOLOGY, 2016, 28 (04) : 1053 - 1069
  • [22] Cannabidiol regulation of emotion and emotional memory processing: relevance for treating anxiety-related and substance abuse disorders
    Lee, Jonathan L. C.
    Bertoglio, Leandro J.
    Guimaraes, Francisco S.
    Stevenson, Carl W.
    BRITISH JOURNAL OF PHARMACOLOGY, 2017, 174 (19) : 3242 - 3256
  • [23] Sympathetic Neural Control in Humans with Anxiety-related Disorders
    Bigalke, Jeremy A.
    Carter, Jason R.
    COMPREHENSIVE PHYSIOLOGY, 2022, 12 (01) : 3085 - 3117
  • [24] Nutritional and herbal supplements for anxiety and anxiety-related disorders: systematic review
    Shaheen E Lakhan
    Karen F Vieira
    Nutrition Journal, 9
  • [25] Imaging the Role of Inflammation in Mood and Anxiety-related Disorders
    Felger, Jennifer C.
    CURRENT NEUROPHARMACOLOGY, 2018, 16 (05) : 533 - 558
  • [26] Use of fluoxetine, diazepam, and behavior modification as therapy for treatment of anxiety-related disorders in dogs
    Ibanez, Miguel
    Anzola, Bernadette
    JOURNAL OF VETERINARY BEHAVIOR-CLINICAL APPLICATIONS AND RESEARCH, 2009, 4 (06) : 223 - 229
  • [27] THE ECONOMIC BURDEN OF PHARMACEUTICALS IN PEOPLE DIAGNOSED WITH DEPRESSION, ANXIETY-RELATED DISORDER AND SUBSTANCE USE IN AUSTRALIA
    Lee, Y.
    Magnus, A.
    Chatterton, M. L.
    Mihalopoulos, C.
    VALUE IN HEALTH, 2015, 18 (07) : A409 - A410
  • [28] Comparing anxiety disorders and anxiety-related traits in bipolar disorder and unipolar depression
    Simon, NM
    Smoller, JW
    Fava, M
    Sachs, G
    Racette, SR
    Perlis, R
    Sonawalla, S
    Rosenbaum, JF
    JOURNAL OF PSYCHIATRIC RESEARCH, 2003, 37 (03) : 187 - 192
  • [29] Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders
    Sartori, Simone B.
    Singewald, Nicolas
    PHARMACOLOGY & THERAPEUTICS, 2019, 204
  • [30] Anxiety, Mood, and Substance Use Disorders in Parents of Children With Anxiety Disorders
    Hughes, Alicia A.
    Furr, Jami M.
    Sood, Erica D.
    Barmish, Andrea J.
    Kendall, Philip C.
    CHILD PSYCHIATRY & HUMAN DEVELOPMENT, 2009, 40 (03) : 405 - 419